Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
植物性API市場預計到2034年將達到520億美元，受迷幻藥和大麻素的推動。
The global plant-based Active Pharmaceutical Ingredient (API) market is projected to grow at a steady pace, reaching a valuation of $52.1 billion by 2034, according to a new report by Future Market Insights. The industry is expected to expand at a Compound Annual Growth Rate (CAGR) of 5.6%, fueled by rising demand for natural and sustainable pharmaceutical solutions, including psychedelics and cannabis-derived compounds.
根據未來市場洞察的最新報告，預計全球植物性活性藥物成分（API）市場將穩步增長，到2034年估值將達到521億美元。該行業預計將以5.6％的複合年增長率（CAGR）擴張，這得益於對包括迷幻藥和大麻衍生化合物在內的天然和可持續藥物解決方案的需求不斷增長。
Rising Demand For Psychedelic And Cannabis-Based Ingredients
對迷幻藥和大麻類成分的需求不斷增加
A significant driver of market growth is the increasing use of psychoactive and plant-derived substances in modern pharmacology. Psychedelics like psilocybin and cannabinoids such as CBD and THC are...
市場增長的一個重要驅動力是現代藥理學中越來越多地使用精神活性...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間